Journal profile

Clinical Diabetes and Endocrinology

ISSN 2055-8260 · eISSN 3059-4057 · BMC · United Kingdom

Clinical Diabetes and Endocrinology: fully open access; APC about USD 3,290; review about 8 weeks (community reports); 2,025 articles a year.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
Review timeabout 8 weeksCommunity average; too few article dates (9)
APCUSD 3,290Fully open access
Acceptance—No reports yet
Articles per year2,025LetPub annual count

Scope

Aims, scope and focus

Clinical Diabetes and Endocrinology is published by BMC. By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins and Diabetes Management and Education, together about 31.1% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)

Cardiovascular Diabetology - Endocrinology Reports, an official companion journal to Cardiovascular Diabetology, is an open access journal publishing on clinical, translational and basic science aspects of endocrinology. The journal welcomes original research, reviews, commentaries and case reports on diabetes and all types of endocrine disorders including, but not limited to, metabolic syndrome, thyroid disorders, adrenal disorders, pituitary disorders, bone disorders, obesity, reproductive disorders and neuroendocrine disorders. The audience includes physicians, researchers, nurses, nutritionists, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists and health care researchers.

From the journal's Aims & Scope

Editor-in-chief Gaetano SantulliPublisher website

Editorial board by country: 5 in mainland China (about 14%); most named United States 7, Italy 6, Mainland China 5, United Kingdom 2, Spain 2 (36 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Diabetes Management and ResearchMedicine12.1%
  2. Diabetes, Cardiovascular Risks, and LipoproteinsMedicine11.2%
  3. Diabetes Management and EducationMedicine7.8%
  4. Diabetes Treatment and ManagementMedicine7.5%
  5. Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology6.6%
  6. Pituitary Gland Disorders and TreatmentsMedicine4.6%
  7. Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine4.6%
  8. Thyroid Disorders and TreatmentsMedicine4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

DOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

EmbaseCASPublisher website

Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
41OpenAlex ·
i10-index
115OpenAlex ·
2-year mean citedness
8.75OpenAlex ·
Share of gold OA articles
0%LetPub ·

Volume

Articles per year (publisher)
2,025Publisher website ·
Downloads per year (publisher) 2025
338,800Publisher website ·

Articles by year OpenAlex count · 205 in total · the current year is incomplete

YearArticlesOpen accessCitations
20245151446
20239993
20229975
20212323617

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

Too few articlesOnly 9 articles from the last 24 months carry both submission and acceptance dates, too few for a median

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 8 weeksLetPub ·
Submission to first decision
4 daysPublisher website ·
Submission to publication (journal-reported)
about 8 weeksDOAJ ·
Peer review
Unspecified peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 2,890 / USD 3,290 / GBP 2,490YesCC BY, CC BY-NC-ND
OpenAlexUSD 2,290 / EUR 1,990 / GBP 1,690——
LetPubGBP 1,590 / USD 2,190 / EUR 1,890Yes—
Publisher websiteGBP 1,690 / USD 2,290 / EUR 1,990——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers2, by deadline
  1. Pleiotropic Actions of Incretin-Based TherapiesDeadline
  2. Endocrine Drivers and Clinical Implications of the Cardiovascular–Kidney–Metabolic SyndromeDeadline
Publisher website
What to prepare1 items from the author guidelines
Suggested reviewers
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted11
  1. case reportResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  2. commentaryResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  3. hypothesisResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  4. letter to the editorResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  5. meeting reportResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  6. methodologyResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  7. perspectiveResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  8. research articleResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  9. review articleResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  10. short reportResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
  11. study protocolResearch article Case report Commentary Review article Short report Meeting report Letter to the Editor Study Protocol Methodology Hypothesis PerspectiveLength not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Open access, Peer review
Authorship

Manuscript must be submitted by an author, not a third party. Model summary

Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.

Source ↗Publisher website ·
Data availability Formatting the 'Availability of data and materials' section of your manuscript

Data availability strongly encouraged or required; deposit in public repositories or present in paper/supporting files; machine-readable format; 'Availability of data and materials' section required. Model summary

The following format for the 'Availability of data and materials section of your manuscript should be used:

Source ↗Publisher website ·
License & copyright Licensing and copyright

Open access under CC BY-NC-ND or CC BY licence; authors retain copyright. Model summary

Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Cardiovascular Diabetology – Endocrinology Reports articles are published open access under a CC BY-NC-ND (C…

Source ↗Publisher website ·
Open access Benefits of open access

Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…

Source ↗Publisher website ·
Peer review Peer review policy

Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
BMC
Country or region
United Kingdom
Language
English
ISSN
2055-8260
Electronic ISSN
3059-4057
Official links

FAQ

Frequently asked questions about Clinical Diabetes and Endocrinology

How long does peer review take at Clinical Diabetes and Endocrinology?

Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Clinical Diabetes and Endocrinology based?

Of the 36 board members whose country the journal's board page names, 5 (about 14%) are in mainland China; the countries named most often are United States (7), Italy (6) and Mainland China (5). Counted from the institutions listed on the board page; for reference only.

Which databases index Clinical Diabetes and Endocrinology?

According to LetPub and DOAJ records, Clinical Diabetes and Endocrinology is indexed in DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.

Is Clinical Diabetes and Endocrinology open access, and what is the APC?

Clinical Diabetes and Endocrinology is a fully open-access journal. APC about USD 3,290.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .